nurofen

Sunday, June 07

Fine for dodgy Nurofen claims increased to $6m

The makers of Nurofen have been fined a record $6 million for misleading consumers over its “specific pain range” tablet claims.

ACCC appeals to raise fine against Nurofen

The consumer watchdog is appealing what it says is an inadequate fine imposed by the Federal Court against the makers of Nurofen over misplaced claims of targeted pain relief.

Nurofen producer ordered to pay $1.7m

The maker of the popular painkiller Nurofen says it didn’t intend to mislead consumers.

Nurofen continues to back down on 'targeted' products

Nurofen will change the packaging on its targeted pain relief products in New Zealand after an Australian ruling found it was selling the same product under different labels.

Nurofen admits to misleading consumers

Back pain? Period pain? Migraines? For Nurofen, it’s all the same.